A standard operative procedure and anaesthetic technique were employed to study the effect of phenothiazine premedication on thiopentone anaesthesia. The premedicants were divided into three groups according to their analgesic action as found 60 to 90 minutes after intramuscular injection. Markedly antanalgesic drugs increase the incidence and severity of excitatory phenomena after thiopentone, but this effect is masked by the use of pethidine. Analgesic and slightly antanalgesic phenothiazines do not affect thiopentone anaesthesia.
A previous paper showed that premedication with hyoscine 0.4 mg resulted in a higher incidence of excitatory phenomena (tremor, spontaneous involuntary muscle movement or hypertonus) following induction with thiopentone 4 mg/kg than when atropine 0.6 mg was used (Dundee, Armstrong and Alexander, 1964) . This effect was less marked than that found after methohexitone, and it did not occur when the antisialogogues were combined with pethidine or papaveretum. It was suggested that this could be explained on the basis of the antanalgesic action of hyoscine as compared with atropine, the latter having neither analgesic nor antanalgesic activity 60 to 90 minutes after subcutaneous or intramuscular injection.
Certain phenothiazine derivatives also have an antanalgesic action 60 to 90 minutes after injection (Dundee, Love and Moore, 1963) , and the use of these in premedication increases the incidence of excitatory phenomena following methohexitone (Dundee and Moore, 1961) . The present study was undertaken to decide if, as is the case with hyoscine, this increase in incidence occurs when thiopentone is used.
METHOD
This was identical with that employed by Dundee, Armstrong and Alexander (1964) . Subjects, consisting of healthy females scheduled for uterine curettage with or without dilatation of the cervix, were premedicated with a phenothiazine derivative and atropine 0.6 mg, about 1 hour before operation. Anaesthesia was induced with thiopentone 4 mg/kg and maintained with 75 per cent nitrous oxide in oxygen, further supplementary doses of barbiturate being injected as required. Observations during and after anaesthesia were made as in the above study.
In view of the limited clinical application of the findings, the effects of individual phenothiazine derivatives were not examined in detail. Three series, each of 100 patients, received the phenothiazine derivatives listed in table I, and the findings in each group are compared with those obtained in a series of 500 patients, anaesthetized with an identical technique, and premedicated with atropine alone. In further series, 100 patients were premedicated with pethidine 100 mg and a markedly antanalgesic phenothiazine derivative, promethazine 50 mg, and the findings compared with a control series who received pethidine-atropine alone. This combination of opiate and phenothiazine derivative was studied because it is commercially available (Pamergan P100) and widely used as a premedication. Table II shows that all series were broadly comparable as regards the age and sex of the patients, and the duration of anaesthesia. Details of the course of anaesthesia in the various series are summarized in table HI. The markedly antanalgesic phenothiazine derivatives increased the incidence of excitatory phenomena to a significant degree, while the frequency of these complications was slightly reduced when analgesic phenothiazine derivatives or opiates were used in premedication. The incidence of excitatory phenomena was slightly greater after the pethidine-antanalgesic phenothiazine combination than after pethidine alone, but the difference between the series did not reach the accepted 5 per cent level of significance.
There were no significant differences between the incidence of respiratory upset (cough, hiccough, or laryngospasm) or marked respiratory depression in different series.
The markedly antanalgesic phenothiazine derivatives were followed by a significantly greater incidence of hypotension than was any other form of premedication. This effect was also observed when the drugs were combined with pethidine.
The overall course of anaesthesia, as assessed by the incidence of the various grades, was significantly worse (x' = 36.8; df = 2; P<0.001) after the use of the antanalgesic phenothiazine derivatives than after atropine. This also applied to a comparison of cases premedicated with pethidine-promethazine and pethidine alone (x 2 = 44.8; df = 2; P<0.001).
When the slightly analgesic phenothiazine derivatives were used a slight reduction of total thiopentone requirements was observed, together with a marked delay in return of consciousness as compared with the corresponding findings with atropine. While total dosage was also decreased with the slightly antanalgesic compounds, recovery was as rapid as in the control series. An increase in total dosage, coupled with a longer sleeping time, occurred after the use of the markedly antanalgesic phenothiazine derivatives and also after pethidine premedication. Thus it would appear that the slightly analgesic phenothiazine derivatives potentiated the anaesthetic action of thiopentone, while the markedly antanalgesic compounds seemed to antagonize the anaesthetic action of the barbiturate.
Emetic sequelae.
The findings, summarized in table IV, show that in none of the groups premedicated with phenothiazine derivatives was there a reduction in emetic sequelae, as compared with the results obtained in the control (atropine) series. Although there was a lower incidence of nausea during the first hour following premedication with pethidine and promethazine than after pethidine, there was no significant difference between the emetic sequelae with these during the first 6 hours after operation ( x 3 = 4.14; df=2; P<0.20).
TABLE IV
Percentage incidence of emetic sequelae during the first hour, 1-6 hours, and the first 6 hours after operation, with the average emetic scores for each group. V=vomiting; N = nausea; when vomiting and nausea both occurred, this was recorded as vomiting.
Atropine

DISCUSSION
This study demonstrates that the phenothiazine derivatives which are markedly antanalgesic increase the incidence of excitatory phenomena following the administration of thiopentone in a manner similar to hyoscine. This effect is not produced by members of the group having slight antanalgesic activity. As was the case with hyoscine, the deleterious effects of the antanalgesic drugs are masked by the use of an opiate. (The higher incidence of unsatisfactory anaesthesia-grades 2b and 3-after pethidine with promethazine, as compared with pethidine alone, is largely due to the hypotension associated with the opiate-phenothiazine mixture rather than to the increase in excitatory phenomena.) A further parallel between the findings in this study and that of hyoscine premedication is the increased total dosage of thiopentone required when markedly antanalgesic drugs are used in premedication. This study again demonstrates that thiopentone is less affected by premedication with drugs having antanalgesic activity than is methohexitone. With the latter there was an increase in excitatory phenomena when phenothiazine derivatives having both slightly and markedly antanalgesic activity were used (Dundee and Moore, 1961) . Unpublished observations show that, in contrast to thiopentone, the undesirable effects on methohexitone anaesthesia of premedication with markedly antanalgesic phenothiazine derivatives are not entirely masked by the use of opiates. The use of thiopentone alone as the only anaesthetic agent for surgical operations is now rare, but this study dearly indicates that premedication with a phenothiazine derivative (particularly promethazine) is to be discouraged if such an anaesthetic technique is contemplated. The combination of pethidine and promethazine (Pamergan P100) does not affect the course of anaesthesia, apart from intensifying the hypotensive action of the thiopentone.
The demonstration of the biphasic analgesic action of all phenothiazines (Dundee, Love and Moore, 1963) suggests that undesirable effects can occur if any phenothiazine derivative is given about 20 minutes before thiopentone, whereas they are not likely to be found if the interval between the administration of the phenothiazine and thiopentone exceeds 2 hours. This paper also confirms the observations of Jaquenoud and Merrier (1951) that the pre-operativc use of potent analgesics, such as pethidine, is a major factor in causing postoperative nausea and vomiting. In agreement with these authors, the results presented here show that the phenothiazine derivatives only reduce that part of the incidence of emetic symptoms attributable to pethidine, and do not reduce the incidence below that occurring when atropine alone is used in premedication.
ETUDES CLIN1QUES DE PRfi-ANESTHfiSIANTS X: L'EFFET DE PR£-M£DICATION DE PHENO-THIAZINE SUR L'ANESTHESIE A THIOPENTONE
SOMMAIRE
Les auteurs ont employ^ un proce<te op^ratoire-standard et une technique d'anesthesie banale pour etudier l'effet de radministration prt-opdratoire de phenothiazine avant anesthesie au thiopentone. Les medicaments de pr£-m6dication pr6-opdratoire sont classes par les auteurs en trois groupes selon leur effet analgesiant apprecte 60 a 90 minutes apres injection intra-musculaire. Des ant-analgesiques nets augmentent incidence et gravity de ph^nomenes d'excitation apres thiopentone, mais leur effet et masque par l'emploi de Pethidine. Les phenothiazines analg^siques et legerement antanalg^siques n'influencent pas l'anestbesie par thiopentone. 
